In obese, human, metabolic syndrome recipients, allogenic fecal microbiota transfer (FMT) using metabolic syndrome donors (vs. post-gastric bypass donors) decreases insulin sensitivity, suggesting that dysbiosis can trigger MUO (39). This evidence concerns the gene INS and metabolic syndrome.